Johnson & Johnson (JNJ)
-NYSE 86.13 
0.23(0.27%) 10:06AM EDT - Nasdaq Real Time Price
| Prev Close: | 86.36 |
|---|
| Open: | N/A |
|---|
| Bid: | 86.10 x 100 |
|---|
| Ask: | 86.13 x 100 |
|---|
| 1y Target Est: | 88.44 |
|---|
| Beta: | 0.38 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 85.90 - 86.46 |
|---|
| 52wk Range: | 66.14 - 89.99 |
|---|
| Volume: | 518,302 |
|---|
| Avg Vol (3m): | 9,715,520 |
|---|
| Market Cap: | 241.93B |
|---|
| P/E (ttm): | 23.38 |
|---|
| EPS (ttm): | 3.68 |
|---|
| Div & Yield: | 2.64 (3.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- Will a New Acquisition Send Johnson & Johnson Prices Higher?at Wall St. Cheat Sheet(Wed 9:04AM EDT)
- Johnson & Johnson: Aragon Pharmaceuticals Is An Excellent Addition For Its Oncology Unitat Seeking Alpha(Wed 9:02AM EDT)
- Should You Buy Stocks Discarded By Warren Buffett ?at Motley Fool(Wed 8:24AM EDT)
- E.U. Fines Drug Companies for Delaying Genericsat New York Times(Wed 7:49AM EDT)
- Is the NBA Going to Sell Obamcare?at Forbes(Wed 12:54AM EDT)
- Ark. AG seeks to uphold verdict against J&JAP(Tue, Jun 18)
- The Top 3 Medical Uses of Botoxat Motley Fool(Tue, Jun 18)
- Call for overhaul of drug industry business modelReuters(Tue, Jun 18)
- JPMorgan Names Co-Chiefs For UK Investment Banking Arm and 2 Other Dow Movers to Watchat Wall St. Cheat Sheet(Tue, Jun 18)
- Final Glance: Medical Devices companiesAP(Tue, Jun 18)
- Final Glance: Pharmaceuticals companiesAP(Tue, Jun 18)
- Should Long-Term Investors Go for Dividends or Blue-Chip Bonds?at Motley Fool(Tue, Jun 18)
- Medtronic’s Infuse No Better Than Bone Graft With Riskat Bloomberg(Tue, Jun 18)
- Nonprofit launches campaign to reach uninsuredAP(Tue, Jun 18)
- The FDA Might Pull This Drug From the Market (and Why It Doesn't Matter)at Motley Fool(Tue, Jun 18)
Key Statistics
| Forward P/E (1 yr): | 14.87 |
|---|
| P/S (ttm): | 3.54 |
|---|
| Ex-Dividend Date: | 23-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.39 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 2.50 |
|---|
Business Summary
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide.
View More